Quarterly report [Sections 13 or 15(d)]

Significant Accounting Policies (Tables)

v3.25.2
Significant Accounting Policies (Tables)
6 Months Ended
Jun. 30, 2025
Accounting Policies [Abstract]  
Schedule of Marketable Securities

The following is a description of the valuation methodologies used for assets measured at fair value as of June 30, 2025 and December 31, 2024.

 

Marketable Securities: Valued using quoted prices in active markets for identical assets.

 

 

    Quoted Prices in Active Markets for Identical Assets or Liabilities (Level 1)     Quoted Prices for Similar Assets or Liabilities in Active Markets (Level 2)     Significant Unobservable Inputs (Level 3)  
Marketable securities at June 30, 2025   $ 3,605,508     $              -     $                -  
                         
Marketable securities at December 31, 2024   $ 8,345,081     $ -     $ -  
Schedule of Fair Value Hierarchy of the Valuation Inputs

 

          As of  
Description   Level    

June 30,

2025

   

December 31,

2024

 
Liabilities                        
Warrant Liabilities     3     $ -     $ -  
Derivative Liabilities     3     $ -     $ 1,303,000  
Summary of Change in Fair Value of Warrant Liabilities

The following table sets forth a summary of the change in the fair value of the warrant liabilities that is measured at fair value on a recurring basis for the six months ended June 30, 2025 and June 30, 2024, respectively:

 

Description   2025     2024  
Balance on December 31, 2024 and 2023   $      -     $ 867,000  
Issuance of warrants reported at fair value     -       -  
Change in fair value of warrant liabilities     -       7,094,000  
Reclassification of warrant liability to equity upon warrant modification     -       (7,961,000 )
Balance on March 31,     -       -  
Issuance of warrants reported at fair value     -       21,992,000  
Change in fair value of warrant liabilities     -       (2,701,000 )
Balance on June 30,   $ -       19,291,000  
Summary of Change in Fair Value of Derivative Liabilities

The following table sets forth a summary of the change in the fair value of the derivative liabilities that is measured at fair value on a recurring basis for the six months ended June 30, 2025 and June 30, 2024, respectively:

 

Description   2025     2024  
Balance on December 31, 2024 and 2023   $ 1,303,000     $ 61,000  
Issuance of derivatives reported at fair value     -       -  
Changes in fair value of derivative liabilities     (1,284,000 )     (61,000 )
Balance on March 31,     19,000       -  
Issuance of derivatives reported at fair value     -       854,000  
Change in fair value of derivative liabilities     (19,000 )     72,000  
Balance on June 30,   $ -     $ 926,000  
Schedule of Estimated Useful Lives of Property Plant and Equipment

The estimated useful lives for the current and comparative periods are as follows:

    

    Useful Life
    (in years)
Plant and equipment   5-12
Furniture and fixtures   5-10
Computer equipment & software   3-5
Leasehold Improvements   Shorter of the remaining lease or estimated useful life
Schedule of Estimated Useful Lives of Intangible Assets

Amortization is recognized on a straight-line basis over the estimated useful lives of intangible assets, other than goodwill, from the date that they are available for use. The estimated useful lives for the current and comparative periods are as follows:

    

    Useful Life
    (in years)
Patents and trademarks   12-17
Schedule of Condensed Consolidated Balance Sheet Information Related to Operating Lease

The Company’s operating leases are comprised of the 2021 Baltimore Lease and the 2024 Baltimore Lease on the Condensed Consolidated Balance Sheets. The information related to these leases is presented below:

 

    2024 Baltimore     Total     2021 Baltimore     2024 Baltimore     Total  
    As of June 30, 2025     As of December 31, 2024  
    2024 Baltimore           2021 Baltimore     2024 Baltimore        
Balance Sheet Location   Lease     Total     Lease     Lease     Total  
Operating Lease                                                             
Lease Right of Use   $ -     $ -     $ -     $ 10,579     $ 10,579  
Lease Payable, current     -       -       -       10,579       10,579  
Lease Payable - net of current     -       -       -       -       -  
Schedule of Lease Expense

The following provides details of the Company’s lease expense:

 

    2024 Baltimore     Total     2021 Baltimore     2024 Baltimore     Total  
    For the Three Months Ended June 30, 2025     For the Three Months Ended June 30, 2024  
    2024 Baltimore           2021 Baltimore     2024 Baltimore        
Lease Expenses   Lease     Total     Lease     Lease     Total  
Operating Leases                                        
Lease Costs   $ 2,700     $ 2,700     $ 4,668     $ 5,400     $ 10,068  

 

Lease Expenses   Lease     Total     Lease     Lease     Total  
    For the Six Months Ended June 30, 2025     For the Six Months Ended June 30, 2024  
    2024 Baltimore           2021 Baltimore     2024 Baltimore        
Lease Expenses   Lease     Total     Lease     Lease     Total  
Operating Leases                                        
Lease Costs   $ 10,800     $ 10,800     $ 18,672     $ 5,400     $ 24,072  
Schedule of Other Information Related to Leases

Other information as of June 30, 2025 related to leases is presented below:

 

    2024 Baltimore        
Other Information   Lease     Total  
Operating Leases                
Operating cash used   $ 10,800     $ 10,800  
Average remaining lease term     -       -  
Average discount rate     10.0 %     10.0 %
Schedule of Anti-dilutive Securities Excluded from Computation of Earnings Per Share

For the three and six months ended June 30, 2025 and 2024, the following securities are excluded from the calculation of weighted average dilutive Common Stock because their inclusion would have been anti-dilutive.

 

    2025     2024                
   

For the Three Months Ended
June 30,

    For the Six Months Ended
June 30,
 
    2025     2024     2025     2024  
Stock Options     281,504       85,226        281,504        85,226  
Unvested Restricted Stock Units     48,334      

48,668

     

48,334

     

48,668

 
Warrants to purchase Common Stock     234,930,021       23,895,139      

234,930,021

     

23,895,139

 
Series C Convertible Preferred Stock Warrants     -       918       -        918   
Series D Convertible Preferred Stock     1,217       1,217       1,217        1,217  
Series F Convertible Preferred Stock     23,919,214       2,574,339       12,038,462       2,574,339  
Series F-1 Convertible Preferred Stock     11,271,834       2,780,837       5,673,077       2,780,837  
Series G Convertible Preferred Stock     47,691,048       4,928,414       24,002,747       4,928,414  
Total potentially dilutive shares     318,143,172       34,314,758       276,975,362       34,314,758